TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases TrimTech Therapeutics, a biotech company that uses targeted protein breakdown (TPD) for the treatment of neurodegenerative diseases, has today announced…
New funding for innovative dementia vaccine research Alzheimer’s disease and frontotemporal dementia are devastating conditions that develop due to the buildup of misfolded proteins in the brain.…
Ignite funding program supports innovative solutions for Canada’s aging population Today, the Center for Aging + Brain Health Innovation (CABHI), powered by Baycrest, launched Ignite, its new funding program to…
